MEDICLIN: Annual General Meeting of MEDICLIN AG Approves All Proposed Resolutions

Offenburg, 10 June 2024: MEDICLIN Aktiengesellschaft (MEDICLIN) held its Annual General Meeting on 6 June as a virtual event. CEO Dr Joachim Ramming expressed satisfaction with the financial performance in 2023, particularly in the post-acute rehabilitation segment. This positive momentum is expected to continue in 2024.

The Supervisory Board welcomed new members: PD Dr Sara Sheikhzadeh, Mr Hafid Rifi, and Mr Joachim Gemmel, enhancing the board's expertise. Dr Jan Liersch, Chairman of the Supervisory Board, highlighted the value these members bring to the company.

The healthcare industry faces challenges like a shortage of skilled labor and impending hospital reforms. CEO Dr Ramming indicated that these reforms will necessitate adaptation in hospital portfolios, particularly affecting the stationary and ambulatory care sectors.

All proposed resolutions were approved by a significant majority at the meeting. Notably, the retention of net retained profits was approved by 99.99%. Additionally, the election of new Supervisory Board members and the appointment of KPMG AG as auditor were confirmed with large majorities.